Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8507)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 7, 2018 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | García-Vilas JA, Medina MÁ. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol 2018; 24(33): 3695-3708 [PMID: 30197476 DOI: 10.3748/wjg.v24.i33.3695] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v24/i33/3695.htm |
| Number | Citing Articles |
| 1 |
Hande Topel, Ezgi Bagirsakci, Dehan Comez, Gulsun Bagci, Gulcin Cakan-Akdogan, Nese Atabey. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00602-0
|
| 2 |
Haiyu Wang, Benchen Rao, Jiamin Lou, Jianhao Li, Zhenguo Liu, Ang Li, Guangying Cui, Zhigang Ren, Zujiang Yu. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00055
|
| 3 |
Mohamed S. Abdel‐Bakky, Hamdoon A. Mohammed, Nesreen I. Mahmoud, Elham Amin, Mansour Alsharidah, Osamah Al Rugaie, Mohamed G. Ewees. Targeting the PI3K/pAKT/mTOR/NF‐κB/FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk. Environmental Toxicology 2024; doi: 10.1002/tox.24217
|
| 4 |
Krizia Pocino, Annunziata Stefanile, Valerio Basile, Cecilia Napodano, Francesca D’Ambrosio, Riccardo Di Santo, Cinzia Anna Maria Callà, Francesca Gulli, Raffaele Saporito, Gabriele Ciasca, Francesco Equitani, Umberto Basile, Mariapaola Marino. Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace. Journal of Personalized Medicine 2022; 13(1): 5 doi: 10.3390/jpm13010005
|
| 5 |
Bettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, Titanilla Dankó, Regina Eszter Raffay, Gábor Petővári, Viktória Zsiros, Anna Sebestyén, Ferenc Sipos, Györgyi Műzes, Vladimir Trajkovic. Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response. PLOS ONE 2022; 17(5): e0268217 doi: 10.1371/journal.pone.0268217
|
| 6 |
Koustav Pal, Rahul A. Sheth. Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions. Cancers 2022; 15(1): 196 doi: 10.3390/cancers15010196
|
| 7 |
Antonio Faiella, Ferdinando Riccardi, Giacomo Cartenì, Martina Chiurazzi, Livia Onofrio, Rengyun Liu. The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5179182
|
| 8 |
Young Yun Jung, Jae‐Young Um, Gautam Sethi, Kwang Seok Ahn. Fangchinoline abrogates growth and survival of hepatocellular carcinoma by negative regulation of c‐met/HGF and its associated downstream signaling pathways. Phytotherapy Research 2022; 36(12): 4542 doi: 10.1002/ptr.7573
|
| 9 |
Wei Meng, Tao Chen. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review). Oncology Reports 2021; 46(3) doi: 10.3892/or.2021.8142
|
| 10 |
Yang Liu, Xia Xiao, Jingying Wang, Yitong Wang, Yanhui Yu. Silencing CircEIF3I/miR-526b-5p Axis Epigenetically Targets HGF/c-Met Signal to Hinder the Malignant Growth, Metastasis and Angiogenesis of Hepatocellular Carcinoma. Biochemical Genetics 2023; 61(1): 48 doi: 10.1007/s10528-022-10239-y
|
| 11 |
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 255 doi: 10.1016/B978-0-323-98807-0.00021-1
|
| 12 |
Wei Chen, Ronghua Wang, Yuchong Zhao, Yawen Li, Xiju Wang, Wang Peng, Shuya Bai, Mengli Zheng, Man Liu, Bin Cheng, Gianpaolo Papaccio. CD44v6+ Hepatocellular Carcinoma Cells Maintain Stemness Properties through Met/cJun/Nanog Signaling. Stem Cells International 2022; 2022: 1 doi: 10.1155/2022/5853707
|
| 13 |
Min Hee Yang, Seung Ho Baek, Jae-Young Um, Kwang Seok Ahn. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2020; 21(21): 8303 doi: 10.3390/ijms21218303
|
| 14 |
An-Na Jiang, Bing Wang, Song Wang, Kun Zhao, Hao Wu, Kun Yan, Wei Wu, Wei Yang. The study of direct and indirect effects of radiofrequency ablation on tumor microenvironment in liver tumor animal model. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09730-x
|
| 15 |
Mengqi Xin. Research and Treatment Progress of Capmatinib in Hepatocellular Carcinoma. Highlights in Science, Engineering and Technology 2022; 8: 576 doi: 10.54097/hset.v8i.1217
|
| 16 |
Ujjwala Karmacharya, Diwakar Guragain, Prakash Chaudhary, Jun-Goo Jee, Jung-Ae Kim, Byeong-Seon Jeong. Novel Pyridine Bioisostere of Cabozantinib as a Potent c-Met Kinase Inhibitor: Synthesis and Anti-Tumor Activity against Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(18): 9685 doi: 10.3390/ijms22189685
|
| 17 |
Yi Zhang, Binyong Liang, Xinhua Song, Haichuan Wang, Matthias Evert, Yi Zhou, Diego F. Calvisi, Liling Tang, Xin Chen. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice. The American Journal of Pathology 2021; 191(5): 930 doi: 10.1016/j.ajpath.2021.01.010
|
| 18 |
Hande Topel, Ezgi Bağırsakçı, Yeliz Yılmaz, Ayşim Güneş, Gülsün Bağcı, Dehan Çömez, Erkan Kahraman, Peyda Korhan, Neşe Atabey. High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89765-5
|
| 19 |
Wancheng Qiu, Yanhua Chang, Jing Liu, Xu Yang, Yan Yu, Jiajia Li, Qing Liang, Guangchun Sun. <p>Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway</p>. OncoTargets and Therapy 2020; : 9481 doi: 10.2147/OTT.S265592
|
| 20 |
Chiara Fedeli, Hector Moreno, Stefan Kunz. The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry. Viruses 2020; 12(8): 857 doi: 10.3390/v12080857
|
| 21 |
Qin He, Zhuoying Lin, Zhihui Wang, Wenjie Huang, Dean Tian, Mei Liu, Limin Xia. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. Oncogene 2020; 39(50): 7279 doi: 10.1038/s41388-020-01500-y
|
| 22 |
Neha Merchant, Afroz Alam, Sujatha Peela, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 273 doi: 10.1016/B978-0-323-98807-0.00025-9
|
| 23 |
Chao Wu, Zuowei Wu, Bole Tian. Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer. BMC Surgery 2020; 20(1) doi: 10.1186/s12893-020-00856-y
|
| 24 |
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. World Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
|
| 25 |
Chi-Chiu Lee, Chia-Jui Yu, Sushree Shankar Panda, Kai-Chi Chen, Kang-Hao Liang, Wan-Chen Huang, Yu-Shiuan Wang, Pei-Chin Ho, Han-Chung Wu. Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04390-2
|
| 26 |
Elisa Holstein, Mathias Binder, Wolfgang Mikulits. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics. International Journal of Molecular Sciences 2018; 19(12): 4111 doi: 10.3390/ijms19124111
|
| 27 |
Xin Liu, Ranran Sun, Jianan Chen, Liwen Liu, Xichun Cui, Shen Shen, Guangying Cui, Zhigang Ren, Zujiang Yu. Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00023
|
| 28 |
Greta Pessino, Claudia Scotti, Maristella Maggi. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. Cancers 2024; 16(5): 901 doi: 10.3390/cancers16050901
|
| 29 |
Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien‐jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei‐Hsuan Lee, Hwai‐I Yang. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individuals. Alimentary Pharmacology & Therapeutics 2021; 54(6): 833 doi: 10.1111/apt.16524
|
| 30 |
Cyril Garcia, Camille Buffet, Laila El Khattabi, Marthe Rizk-Rabin, Karine Perlemoine, Bruno Ragazzon, Jérôme Bertherat, Françoise Cormier, Lionel Groussin. MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer. Oncotarget 2019; 10(23): 2320 doi: 10.18632/oncotarget.26798
|
| 31 |
Birgit Lohberger, Susanne Scheipl, Ellen Heitzer, Franz Quehenberger, Danielle de Jong, Karoly Szuhai, Bernadette Liegl-Atzwanger, Beate Rinner. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92018-0
|
| 32 |
Srinivas Reddy Pallerla, Nghiem Xuan Hoan, Sivaramakrishna Rachakonda, Christian G. Meyer, Hoang Van Tong, Nguyen Linh Toan, Le Thi Kieu Linh, Dao Phuong Giang, Peter G. Kremsner, Mai Hong Bang, Le Huu Song, Thirumalaisamy P. Velavan. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01386-7
|
| 33 |
Mingyuan Zhao, Yinhe Wang, Yan Liu, Wanchun Zhang, Yakun Liu, Xiaoming Yang, Yunxia Cao, Siying Wang. C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway. Cancer Biology & Therapy 2019; 20(12): 1430 doi: 10.1080/15384047.2019.1647051
|
| 34 |
Nehad M. Ayoub, Amer E. Alkhalifa, Dalia R. Ibrahim, Ahmed Alhusban. Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor. Medical Oncology 2021; 38(1) doi: 10.1007/s12032-021-01458-1
|
| 35 |
Cindy Lobe, Marie Vallette, Ander Arbelaiz, Ester Gonzalez‐Sanchez, Laura Izquierdo, Anna Pellat, Nathalie Guedj, Corentin Louis, Valérie Paradis, Jesus M Banales, Cédric Coulouarn, Chantal Housset, Javier Vaquero, Laura Fouassier. Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling. Hepatology 2021; 74(6): 3194 doi: 10.1002/hep.32069
|
| 36 |
M. Murali, A. R. Kumar, B. Nair, K. Pavithran, A. R. Devan, G. K. Pradeep, L. R. Nath. Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance. Clinical and Translational Oncology 2022; 24(3): 407 doi: 10.1007/s12094-021-02707-5
|
| 37 |
Samantha M. Ruff, Timothy M. Pawlik. Emerging therapies targeting growth factors in hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2024; : 1 doi: 10.1080/14656566.2024.2340714
|
| 38 |
Zhiwei Shao, Haoqi Pan, Sheng Tu, Jingying Zhang, Sheng Yan, Anwen Shao. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00801
|
| 39 |
Christian Liedtke, Yulia A. Nevzorova, Tom Luedde, Henning Zimmermann, Daniela Kroy, Pavel Strnad, Marie-Luise Berres, Jürgen Bernhagen, Frank Tacke, Jacob Nattermann, Ulrich Spengler, Tilman Sauerbruch, Alexander Wree, Zeinab Abdullah, René H. Tolba, Jonel Trebicka, Twan Lammers, Christian Trautwein, Ralf Weiskirchen. Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.814496
|
| 40 |
Qin-Liang Fang, Jian-Yin Zhou, Yu Xiong, Cheng-Rong Xie, Fu-Qiang Wang, Yun-Tong Li, Zhen-Yu Yin, Guo-Hui Luo. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20200297
|
| 41 |
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024; 5(2) doi: 10.1002/mco2.474
|
| 42 |
Ishfaq Hassan Mir, K. C. Jyothi, Chinnasamy Thirunavukkarasu. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation. Journal of Cellular Biochemistry 2022; 123(10): 1607 doi: 10.1002/jcb.30190
|
| 43 |
Haixing Liao, Muneeb Ahmed, Aurelia Markezana, Guohua Zeng, Matthias Stechele, Eithan Galun, S. Nahum Goldberg. Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model. Radiology 2020; 294(2): 464 doi: 10.1148/radiol.2019191023
|
| 44 |
Valeria De Pasquale, Luigi Michele Pavone. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment. International Journal of Molecular Sciences 2020; 21(18): 6588 doi: 10.3390/ijms21186588
|
| 45 |
Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, Carlo Resteghini, Donata Galbiati, Paolo Bossi, Federica Perrone, Elena Tamborini, Pasquale Quattrone, Lisa Licitra, Laura Deborah Locati, Salvatore Alfieri. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?. Expert Opinion on Investigational Drugs 2019; 28(5): 435 doi: 10.1080/13543784.2019.1598376
|
| 46 |
Mohamed Omran, Manar Fouda, Abdelwahab Osama Abdelwahab, Mohamed Mahmoud Nabeel, Ashraf Omar Abdelaziz, Dalia Omran, Hend Ibrahim Shousha. P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study. European Journal of Gastroenterology & Hepatology 2022; 34(2): 220 doi: 10.1097/MEG.0000000000001962
|
| 47 |
Shenjun Yuan, Yuyuan Gong, Ruobing Chen, Juan Du, Hongfeng Zhang, Tao Chen. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. Biomedicine & Pharmacotherapy 2020; 132: 110867 doi: 10.1016/j.biopha.2020.110867
|
| 48 |
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01924-w
|